These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22381020)

  • 1. β-cell dysfunction and the onset of type 2 diabetes.
    Fennoy I
    J Pediatr; 2012 Jun; 160(6):895-6. PubMed ID: 22381020
    [No Abstract]   [Full Text] [Related]  

  • 2. Disordered insulin secretion in the development of insulin resistance and Type 2 diabetes.
    Schofield CJ; Sutherland C
    Diabet Med; 2012 Aug; 29(8):972-9. PubMed ID: 22443306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and biochemical pathways of beta-cell failure in type 2 diabetes.
    Talchai C; Lin HV; Kitamura T; Accili D
    Diabetes Obes Metab; 2009 Nov; 11 Suppl 4():38-45. PubMed ID: 19817787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus.
    Defronzo RA
    Diabetes; 2009 Apr; 58(4):773-95. PubMed ID: 19336687
    [No Abstract]   [Full Text] [Related]  

  • 5. Pathogenesis of type 2 diabetes.
    Stumvoll M; Goldstein BJ; van Haeften TW
    Endocr Res; 2007; 32(1-2):19-37. PubMed ID: 18271503
    [No Abstract]   [Full Text] [Related]  

  • 6. Pancreatic beta-cell mass or beta-cell function? That is the question!
    Henquin JC; Cerasi E; Efendic S; Steiner DF; Boitard C
    Diabetes Obes Metab; 2008 Nov; 10 Suppl 4():1-4. PubMed ID: 18834427
    [No Abstract]   [Full Text] [Related]  

  • 7. Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test.
    Festa A; Williams K; Hanley AJ; Haffner SM
    Diabetes; 2008 Jun; 57(6):1638-44. PubMed ID: 18332099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between beta-cell mass and diabetes onset.
    Matveyenko AV; Butler PC
    Diabetes Obes Metab; 2008 Nov; 10 Suppl 4(0 4):23-31. PubMed ID: 18834430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Compensation and distress in pancreatic beta cells].
    Ogihara T; Watada H
    Nihon Rinsho; 2012 May; 70 Suppl 3():113-7. PubMed ID: 22768506
    [No Abstract]   [Full Text] [Related]  

  • 10. The required beta cell research for improving treatment of type 2 diabetes.
    Thorens B
    J Intern Med; 2013 Sep; 274(3):203-14. PubMed ID: 23751050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta cell dynamics: beta cell replenishment, beta cell compensation and diabetes.
    Cerf ME
    Endocrine; 2013 Oct; 44(2):303-11. PubMed ID: 23483434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance causes increased beta-cell mass but defective glucose-stimulated insulin secretion in a murine model of type 2 diabetes.
    Asghar Z; Yau D; Chan F; Leroith D; Chan CB; Wheeler MB
    Diabetologia; 2006 Jan; 49(1):90-9. PubMed ID: 16362284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β cell dysfunction versus insulin resistance in the pathogenesis of type 2 diabetes in East Asians.
    Yabe D; Seino Y; Fukushima M; Seino S
    Curr Diab Rep; 2015 Jun; 15(6):602. PubMed ID: 25944304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance, β-cell dysfunction and differences in curves of plasma glucose and insulin in the intermediate points of the standard glucose tolerance test in adults with cystic fibrosis.
    Cano Megías M; González Albarrán O; Guisado Vasco P; Lamas Ferreiro A; Máiz Carro L
    Endocrinol Nutr; 2015 Feb; 62(2):91-9. PubMed ID: 25444978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Endoplasmic reticulum stress: from physiology to pathogenesis of type 2 diabetes].
    Flamment M; Foufelle F
    Med Sci (Paris); 2013; 29(8-9):756-64. PubMed ID: 24005631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five stages of progressive β-cell dysfunction in the laboratory Nile rat model of type 2 diabetes.
    Yang K; Gotzmann J; Kuny S; Huang H; Sauvé Y; Chan CB
    J Endocrinol; 2016 Jun; 229(3):343-56. PubMed ID: 27068697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing the Concept of Type 2 Diabetes: Beta Cell Workload Hypothesis Revisited.
    Saisho Y
    Endocr Metab Immune Disord Drug Targets; 2019; 19(2):121-127. PubMed ID: 30173655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central infusion of leptin improves insulin resistance and suppresses beta-cell function, but not beta-cell mass, primarily through the sympathetic nervous system in a type 2 diabetic rat model.
    Park S; Ahn IS; Kim DS
    Life Sci; 2010 Jun; 86(23-24):854-62. PubMed ID: 20388519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-Cell function in type 2 diabetes.
    Ferrannini E; Mari A
    Metabolism; 2014 Oct; 63(10):1217-27. PubMed ID: 25070616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin resistance or hypersecretion? The βIG picture revisited.
    Goel P
    J Theor Biol; 2015 Nov; 384():131-9. PubMed ID: 26300065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.